Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899769 · ClinicalTrials.gov registry record
Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 100
- Enrollment target
NCT00899769: Completed study, sponsored by Vanderbilt University Medical Center.
NCT00899769 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00899769 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood, tissue, and saliva in the laboratory from patients with cancer and from healthy volunteers may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with head and neck cancer and in healthy volunteers.
Interventions
- GENETIC protein expression analysis
- OTHER laboratory biomarker analysis
- OTHER immunoenzyme technique
- OTHER liquid chromatography
- GENETIC proteomic profiling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-04 |
What the finished NCT00899769 record still lists
NCT00899769 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which protein expression analysis is the first listed.
NCT00899769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00899769 about?
NCT00899769 is a clinical study titled "Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers". RATIONALE: Studying samples of blood, tissue, and saliva in the laboratory from patients with cancer and from healthy volunteers may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with head and neck cancer...
What is the current status of trial NCT00899769?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2005-04.
What interventions are being tested in trial NCT00899769?
The interventions under investigation include: protein expression analysis (GENETIC), laboratory biomarker analysis (OTHER), immunoenzyme technique (OTHER), liquid chromatography (OTHER), proteomic profiling (GENETIC).
Who is sponsoring clinical trial NCT00899769?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia